Heritability of Clot Formation, Morphology, and Lysis
- 1 December 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (12), 2783-2789
- https://doi.org/10.1161/atvbaha.107.153221
Abstract
Objective— The relative balance between clot formation and fibrinolysis is considered to reflect thrombotic potential following vascular injury. The aims of the present study were to (1) to determine the contribution of genetic and environmental factors to variance in measures of clot structure/function in the Leeds Family Study, and (2) to determine the relationship between measures of clot structure/function and cardiovascular risk. Methods and Results— Using high throughput turbidimetric assays, heritabilities of measures of clot formation, clot structure, and clot lysis were ≈0.30. Fibrinogen contributed to variance in all measures and plasminogen activator inhibitor-1 to variance in lysis variables. Subjects at increased cardiovascular risk due to the presence of the metabolic syndrome (MetS) had increased clot density (MaxAbs C : 0.358 [0.340, 0.375]au) and prolonged lysis times (Lys T : 510 [6569, 7939]s) compared with those without MetS (MaxAbs C : 0.319 [0.310, 0.328]au, P =0.003; Lys T : 7221 [4884, 5328]s, P Conclusions— This study indicates that genetic factors contribute modestly to variance in clot structure/function and that clot structure/function is related to presence of the MetS and number of MetS components. Identification of the genetic and environmental factors influencing clot structure/function may further our understanding of the underlying factors predisposing to cardiovascular disease.Keywords
This publication has 28 references indexed in Scilit:
- Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all‐cause mortality – results of prospective analysis for the Atherosclerosis Risk in Communities studyJournal of Internal Medicine, 2007
- Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery diseaseJournal of Thrombosis and Haemostasis, 2006
- Genetic influence on thrombotic risk markers in the elderly – a Danish twin studyJournal of Thrombosis and Haemostasis, 2005
- Reduced plasma fibrinolytic potential is a risk factor for venous thrombosisBlood, 2005
- A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarctionJournal of the American College of Cardiology, 2005
- Genetics of fibrin clot structure: a twin studyBlood, 2004
- Genetic and environmental influences on the fibrinolytic system: a twin studyThrombosis and Haemostasis, 2004
- Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery DiseaseCirculation, 2002
- Genetic Susceptibility to Thrombosis and Its Relationship to Physiological Risk Factors: The GAIT StudyAmerican Journal of Human Genetics, 2000
- Native fibrin gel networks observed by 3D microscopy, permeation and turbidityBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989